RTS,S/AS01 (RTS,S)
What is it?
- It is the world’s first antimalarial vaccine , known by the brand name Mosquirix.
- It is the world’s first licensed malaria vaccine and also the first vaccine licensed for use against a human parasitic disease of any kind.
Why in News:
- The World Health Organization (WHO) is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children in sub-Saharan Africa and in other regions with moderate to high P. falciparum malaria transmission.
About the vaccine
- The vaccine does significantly reduce life-threatening severed malaria.
- Vaccination against malaria does not replace or reduce the need for other measures, including bed nets.
What is malaria?
- Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. It is preventable and curable.
- Malaria is caused by Plasmodium parasites. The parasites are spread to people through the bites of infected female Anopheles mosquitoes, called “malaria vectors.”
- After entering the human body, parasites initially multiply within the liver cells and then attack the Red Blood Cells (RBCs) resulting in their rupture.
- There are 5 parasite species that cause malaria in humans, and 2 of these species – Plasmodium falciparum and Plasmodium vivax – pose the greatest threat.
- In 2019, there were an estimated 229 million cases of malaria worldwide.
- To read more about Malaria, its effect in India and various government initiatives, read: https://officerspulse.com/malaria/
- To read more about World Malaria Report 2020: https://officerspulse.com/world-malaria-report-2020/
References:
- https://www.thehindu.com/sci-tech/health/world-health-organization-recommends-first-anti-malarial-vaccine/article36867500.ece
- https://www.who.int/news/item/06-10-2021-who-recommends-groundbreaking-malaria-vaccine-for-children-at-risk
Subscribe
Login
0 Comments